Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Testing effectiveness (Phase 2)Study completedNCT00113360
What this trial is testing

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine CarcinomaIslet Cell Carcinoma
M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)Ended earlyNCT03042780
What this trial is testing

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorPancreatic CancerNeuroendocrine Carcinomas of Pancreas+1 more
H. Lee Moffitt Cancer Center and Research Institute 2
Post-approval studies (Phase 4)Study completedNCT00578279
What this trial is testing

Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study

Who this might be right for
Pancreatic Cancer
Indiana University 20
Not applicableStudy completedNCT00909103
What this trial is testing

Endoscopic Ultrasound Elastography in Pancreatic Masses

Who this might be right for
Pancreatic AdenocarcinomaChronic Pancreatitis
University of Medicine and Pharmacy Craiova 285
Testing effectiveness (Phase 2)Study completedNCT04752696
What this trial is testing

Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Cardiff Oncology 41
Testing effectiveness (Phase 2)Ended earlyNCT01484860
What this trial is testing

Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Disease
University Health Network, Toronto 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT01369420
What this trial is testing

NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Angiodynamics, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT01313416
What this trial is testing

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsCancer of the PancreasNeoplasms Pancreatic+2 more
Augusta University 2
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Ended earlyNCT06069778
What this trial is testing

Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
BioNTech SE 1
Not applicableStudy completedNCT03695835
What this trial is testing

A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

Who this might be right for
Adenocarcinoma
Gary Onik MD 27
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03856658
What this trial is testing

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic AdenocarcinomaLiver Metastases
Corewell Health West 14
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Looking for participantsNCT06904378
What this trial is testing

ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine 61
Very early researchWithdrawnNCT06284226
What this trial is testing

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Who this might be right for
Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)
Beijing Kejing Biotechnology Co., Ltd.
Not applicableStudy completedNCT04467593
What this trial is testing

Safety Study of Whole Body Hyperthermia for Advanced Cancer

Who this might be right for
Advanced CancerPancreatic Cancer Metastatic
ElmediX 16
Next Page